Differences in gut microbiota composition in metabolic syndrome and type 2 diabetes subjects in a multi-ethnic population: the HELIUS study
Mélanie Deschasaux(Inserm), Max Nieuwdorp(Amsterdam Institute for Addiction Research), Aeilko H. Zwinderman(Amsterdam Neuroscience), Hilde Herrema(Amsterdam Neuroscience), Andrei Prodan(AstraZeneca (Netherlands)), Kristien E. Bouter(Amsterdam UMC Location University of Amsterdam), Marieke B. Snijder(GGD Amsterdam), Valentina Tremaroli(University of Gothenburg), Evgeni Levin(Horse Hospital), Albert K. Groen(Amsterdam University Medical Centers), Mary Nicolaou(Department of Public), Fredrik Bäckhed(Sahlgrenska University Hospital)
Cited by 11
Related Papers
Obesity alters gut microbial ecology
|Proceedings of the National Academy of Sciences|2005|6.1k
Bivariate analysis of sensitivity and specificity produces informative summary measures in diagnostic reviews
|Journal of Clinical Epidemiology|2005|3.3k
Metformin alters the gut microbiome of individuals with treatment-naive type 2 diabetes, contributing to the therapeutic effects of the drug
|Nature Medicine|2017|1.6k
Simvastatin with or without Ezetimibe in Familial Hypercholesterolemia
|New England Journal of Medicine|2008|1.2k
Enterotypes in the landscape of gut microbial community composition
|Nature Microbiology|2017|1.2k